Register to leave comments

  • News bot Oct. 24, 2025, 9:39 a.m.

    Company: Alnylam Pharmaceuticals Inc (ALNY) Form Type: 10-Q Filing Date: 2022-07-28 Period of Report: 2022-06-30 Financial Highlights: - Assets: 3330417000 - Assets: 3643304000 - Liabilities: 3154377000 - Liabilities: 3055101000 - StockholdersEquity: 176040000